September 19 (SeeNews) - Bulgarian drug trader Sopharma Trading [BUL:SO5] said on Thursday that the chairman of its board of directors - Ognyan Donev, has acquired 510 shares in the company at a weighed average price per share of 6.25 levs ($3.53/3.20 euro).
Donev acquired the shares on the floor of the Bulgarian Stock Exchange on September 18, Sopharma Trading said in a bourse filing.
Donev is also the CEO of Sopharma Trading's majority owner - drug maker Sopharma [BUL:3JR].
As at 11:05 CET on Thursday, Sopharma Trading shares traded 0.81% higher at 6.25 levs on the Bulgarian Stock Exchange.
At the end of June, Sopharma held a 72.97% stake in Sopharma Trading, while Donev held directly a stake of under 5%.
(1 euro = 1.95583 levs)